Literature DB >> 18756194

Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.

.   

Abstract

Nigeria is one of only four countries that have never interrupted poliovirus transmission (the others are Afghanistan, India, and Pakistan). A resurgence in wild poliovirus (WPV) transmission occurred in Nigeria during 2003-2004 after a loss of public confidence in oral poliovirus vaccine (OPV) and suspension of supplementary immunization activities (SIAs)* in several northern states. Subsequently, WPV spread within Nigeria and ultimately into 20 previously polio-free countries during 2003-2006. Even after national SIAs resumed, limited acceptance and ongoing operational problems resulted in low polio vaccination coverage and continued WPV transmission. Beginning in 2006, health authorities in Nigeria introduced new initiatives to control the spread of WPV, including a focus on interrupting type 1 WPV (WPV1) transmission and use of monovalent type 1 OPV (mOPV1) for most of the SIAs to increase vaccine effectiveness. Nigeria also instituted changes in SIA implementation to increase community acceptance of vaccination. Subsequently, 285 polio cases were reported in Nigeria in 2007, the lowest number since sensitive surveillance has been in place. As of August 12, 2008, confirmed polio cases reported in Nigeria totaled 556 (including 511 WPV1 cases), compared with 176 cases (53 WPV1) reported during the same period in 2007. This report updates overall progress toward polio eradication in Nigeria during 2007-2008. Given the increase in WPV transmission thus far in 2008, urgent measures are needed to reach all children during SIAs to bring WPV under control in Nigeria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756194

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Immunity to poliovirus serotypes in children population of selected communities in South-west, Nigeria.

Authors:  Johnson Adekunle Adeniji; Folakemi Abiodun Osundare; Olubusuyi Moses Adewumi; Anyebe Bernard Onoja; Ademola Hezekiah Fagbami
Journal:  Afr J Infect Dis       Date:  2015

2.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

Authors:  Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van der Avoort
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Has Wild Poliovirus Been Eliminated from Nigeria?

Authors:  Michael Famulare
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

4.  Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study.

Authors:  Deborah Watson-Jones; Keith Tomlin; Pieter Remes; Kathy Baisley; Riziki Ponsiano; Selephina Soteli; Silvia de Sanjosé; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

5.  World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.

Authors:  Yared G Yehualashet; Alieu Wadda; Koffi B Agblewonu; Theophilus Zhema; Al-Asi A Ibrahim; Alhagie Corr; Jennifer Linkins; Pascal Mkanda; Rui G Vaz; Peter Nsubuga; Daniel Ashogbon
Journal:  J Infect Dis       Date:  2016-02-21       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.